SCHEMBL13636749

SCHEMBL13636749

Fc1cccc(/C=C/c2ccc(N(c3ccc(/C=C/c4cccc(F)c4)cc3)c3ccc(/C=C/c4cccc(F)c4)cc3)cc2)c1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NFE2L2 Q16236 12/20 0.71
RELA Q04206 1/20 0.59
PTGS1 P23219 3/20 0.58
NQO2 P16083 1/20 0.58
PTGS2 P35354 1/20 0.55
FBP1 P09467 1/20 0.47
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2D6 P10635 1/20 0.47
PKM P14618 1/20 0.47
MAPK1 P28482 1/20 0.47
THPO P40225 1/20 0.47
NPC1 O15118 1/20 0.47
CHRM5 P08912 1/20 0.47
GRM5 P41594 1/20 0.47
RAB9A P51151 1/20 0.47
BLM P54132 1/20 0.47
PMP22 Q01453 1/20 0.47
MAOA P21397 1/20 0.46
MAOB P27338 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9849735 0.88 NFE2L2 (0.91) NFE2L2RELAPTGS1NQO2PTGS2
SCHEMBL29404131 0.85 NFE2L2 (0.67) NFE2L2RELAPTGS1NQO2PTGS2
SCHEMBL11895254 0.85 NFE2L2 (0.67) NFE2L2RELAPTGS1NQO2PTGS2
SCHEMBL11895252 0.85 NFE2L2 (0.67) NFE2L2RELAPTGS1NQO2PTGS2
SCHEMBL698584 0.84 NFE2L2 (1.00) NFE2L2RELAPTGS1NQO2PTGS2
SCHEMBL698583 0.84 NFE2L2 (1.00) NFE2L2RELAPTGS1NQO2PTGS2
SCHEMBL700536 0.83 NFE2L2 (1.00) NFE2L2RELAPTGS1NQO2PTGS2
SCHEMBL31317689 0.83 NFE2L2 (1.00) NFE2L2RELAPTGS1NQO2PTGS2
SCHEMBL700537 0.83 NFE2L2 (1.00) NFE2L2RELAPTGS1NQO2PTGS2
SCHEMBL13636750 0.82 APP (0.50) NFE2L2PTGS1NQO2PTGS2APP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1957605-B1 ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2017-01-11 EP disclosed
US-8304095-B2 Organic electroluminescent devices MERCK PATENT GMBH (DE) 2012-11-06 US disclosed
US-8304095-B2 Organic electroluminescent devices MERCK PATENT GMBH (DE) 2012-11-06 US disclosed
US-20080272693-A1 Organic Electroluminescent Devices MERCK PATENT GMBH (DE) 2008-11-06 US disclosed
US-20080272693-A1 Organic Electroluminescent Devices MERCK PATENT GMBH (DE) 2008-11-06 US disclosed
WO-2007065549-A1 ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2007-06-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080272693-A1 Organic Electroluminescent Devices EML4, MT-ND4L, EPCAM NFE2L2 423/4885RELA 2586/4885PTGS1 4105/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.